PICTURES

Sputnik V 75% effective against Omicron: Vaccine developer

Rate this post


  • The Sputnik V effectiveness against Omicron decreases by eight instances however it’s nonetheless sufficient for cover, Alexander Gintsburg stated, including that the effectiveness of different vaccines decreases by 21 instances.

- Advertisement-
Updated On Jan 18, 2022 05:38 PM IST 5 Photos

1 / 5

- Advertisement-
The head of Russia's Gamaleya Research Center, Alexander Gintsburg, on Tuesday said that the effectiveness of the Sputnik V Covid-19 vaccine against the Omicron coronavirus variant is 75 per cent.

The head of Russia’s Gamaleya Research Center, Alexander Gintsburg, on Tuesday stated that the effectiveness of the Sputnik V Covid-19 vaccine against the Omicron coronavirus variant is 75 per cent.

Updated on Jan 18, 2022 05:38 PM IST

2 / 5

"In the population, the effectiveness of the Sputnik V vaccine in relation to Omicron ... is 75 per cent," Alexander Gintsburg said in the Rossiya Segodnya press center.

“In the population, the effectiveness of the Sputnik V vaccine in relation to Omicron … is 75 per cent,” Alexander Gintsburg stated within the Rossiya Segodnya press heart.

Updated on Jan 18, 2022 05:38 PM IST
- Advertisement-

3 / 5

“Protection against Omicron increases to 100% if a person receives a Sputnik Light booster dose in six months but decreases to 56-57% if revaccination is not done," he further said about the booster dose.

“Protection against Omicron will increase to 100% if an individual receives a Sputnik Light booster dose in six months however decreases to 56-57% if revaccination is just not executed,” he additional stated in regards to the booster dose.

Updated on Jan 18, 2022 05:38 PM IST
- Advertisement-

4 / 5

Last week, Hyderabad-based biotechnology firm Bharat Biotech also said that the "Booster dose of Covaxin generated robust neutralising antibody responses against both Omicron and Delta variants of SARS-CoV-2.

Last week, Hyderabad-based biotechnology agency Bharat Biotech additionally stated that the “Booster dose of Covaxin generated sturdy neutralising antibody responses against each Omicron and Delta variants of SARS-CoV-2.

Updated on Jan 18, 2022 05:38 PM IST

5 / 5

"The neutralisation activity of Covaxin-boosted sera was comparable to what has been observed in mRNA vaccine-boosted sera against the Omicron variant," Bharat Biotech said in a statement.

“The neutralisation activity of Covaxin-boosted sera was comparable to what has been observed in mRNA vaccine-boosted sera against the Omicron variant,” Bharat Biotech stated in an announcement.

Updated on Jan 18, 2022 05:38 PM IST
SHARE
- Advertisement-

Stay Tuned with Sociallykeeda.com for more Entertainment information.

Back to top button

Adblock Detected

Please consider supporting us by disabling your ad blocker
close button
MODPLAY supports free Android games download. Thousands of top best Android